MESOBLAST LTD- SPON ADR (MESO:NASDAQ)
$15.48 -0.02 (-0.129%)
Analysed MESOBLAST LTD- SPON ADR (MESO:NASDAQ) News Sources
Mesoblast Limited (MESO) is a Great Momentum Stock: Should You Buy?
17-07-2026
yahoo.com
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
30-07-2026
yahoo.com
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17-08-2026
yahoo.com
Sector Update: Healthcare Stocks Mixed Monday Afternoon
17-08-2026
yahoo.com
Mesoblast Financial Results and Corporate Update Webcast
24-08-2026
yahoo.com
MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up
18-08-2026
yahoo.com
Mesoblast shares jump as Phase 3 chronic back pain trial completes patient treatment
17-08-2026
advfn.com
3 Australian Growth Stocks With Strong Balance Sheets In A Rate Hike Debate
26-08-2026
yahoo.com
Mesoblast H2 Earnings Call Highlights
27-08-2026
marketbeat.com
Mesoblast Reports Substantial Revenue Growth to US$120M
27-08-2026
yahoo.com
What is the current price of MESOBLAST LTD- SPON ADR (MESO:NASDAQ)?
The current price of MESOBLAST LTD- SPON ADR (MESO:NASDAQ) is $15.48.
MESOBLAST LTD- SPON ADR (MESO:NASDAQ) absolute price change since previous trading day?
The absolute price change of MESOBLAST LTD- SPON ADR (MESO:NASDAQ) since the previous trading day is $-0.02.
MESOBLAST LTD- SPON ADR (MESO:NASDAQ) percentage price change since previous trading day?
The percentage price change of MESOBLAST LTD- SPON ADR (MESO:NASDAQ) since the previous trading day is -0.129%.
What is the most recent average sentiment score for MESOBLAST LTD- SPON ADR (MESO:NASDAQ)?
The most recent average sentiment score for MESOBLAST LTD- SPON ADR (MESO:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for MESOBLAST LTD- SPON ADR (MESO:NASDAQ)?
The most recent sentiment for MESOBLAST LTD- SPON ADR (MESO:NASDAQ) is .
SEC-8K** Filing Available For MESOBLAST LTD- SPON ADR (MESO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.